(HealthDay News) — For patients with poorly controlled type 2 diabetes, pump treatment is associated with improved glycemic control vs. multiple daily injections, according to a study published online ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify [email protected] if there are concerns regarding accuracy of the transcription.

Researchers have created a slow-release ‘smart’ insulin that responds to blood glucose levels to provide week-long control with virtually no incidents of low blood sugar. Tested in mice and minipigs, ...

Most of the 38 million people living with diabetes in the U.S. use daily injections or insulin pumps to keep glucose at safe levels — but new research suggests that a third option could be just as ...

Please provide your email address to receive an email when new articles are posted on . Patients receiving injections of autologous adipose-derived stem cells or adipose-derived stromal vascular ...